Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer
Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer
Arimidex Continues To Show Improvement Over Tamoxifen
Iressa May Benefit Some Breast Cancer, Studies Find
Gleevec Improves Survival Of CML In Accelerated Phase
Phase II Study Tests Chemo Plus Mylotarg For AML
“Proof Of Concept” Shown In Early Trial Of PKC-412
Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis
Clinical Trials Approved By NCI During November Are Listed
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Brown University reaches agreement with Trump administration to restore funding
- The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”
